HYLAFORM AND HYLAFORM PLUS

FDA Premarket Approval P030032 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for an extension of the hylaform and hylaform plus shelf life from 24 to 36 months.

DeviceHYLAFORM AND HYLAFORM PLUS
Generic NameImplant, Dermal, For Aesthetic Use
ApplicantGENZYME BIOSURGERY
Date Received2005-09-23
Decision Date2005-11-02
PMAP030032
SupplementS004
Product CodeLMH 
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address GENZYME BIOSURGERY 55 Cambridge Parkway cambridge, MA 02142

Supplemental Filings

Supplement NumberDateSupplement Type
P030032Original Filing
S017 2014-08-08 30-day Notice
S016 2013-09-25 135 Review Track For 30-day Notice
S015
S014 2011-12-20 135 Review Track For 30-day Notice
S013 2011-09-02 30-day Notice
S012 2011-05-27 Real-time Process
S011
S010 2010-06-09 135 Review Track For 30-day Notice
S009 2009-09-11 30-day Notice
S008 2009-04-15 Normal 180 Day Track No User Fee
S007 2007-07-25 Normal 180 Day Track
S006
S005 2006-01-27 Normal 180 Day Track No User Fee
S004 2005-09-23 Real-time Process
S003 2005-04-20 Normal 180 Day Track No User Fee
S002 2004-07-28 Normal 180 Day Track
S001 2004-06-22 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.